CXCL12 impact on glioblastoma cells behaviors under dynamic culture conditions: Insights for developing new therapeutic approaches.
Glioblastoma multiforme (GBM) is the most prevalent malignant brain tumor, with an average survival time of 14 to 20 months. Its capacity to invade brain parenchyma leads to the failure of conventional treatments and subsequent tumor recurrence. Recent studies have explored new therapeutic strategie...
Saved in:
Main Authors: | Wiam El Kheir, Sahar Naasri, Bernard Marcos, Nick Virgilio, Benoit Paquette, Nathalie Faucheux, Marc-Antoine Lauzon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0315038 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expressions of CXCL12/CXCR4 in Oral Premalignant and Malignant Lesions
by: Juan Xia, et al.
Published: (2012-01-01) -
Stromal-Cell-Derived Factor-1 (SDF-1)/CXCL12 as Potential Target of Therapeutic Angiogenesis in Critical Leg Ischaemia
by: Teik K. Ho, et al.
Published: (2012-01-01) -
Clinicopathologic Significance of CXCL12 and CXCR4 Expressions in Patients with Colorectal Cancer
by: Naomi Yoshuantari, et al.
Published: (2018-01-01) -
Serum CXCL12 and S100A12 levels in peripheral blood fluid and their correlation with severity in patients with knee osteoarthritis
by: LijiangTao, et al.
Published: (2025-01-01) -
Transcriptomic signatures of cold acclimated adipocytes reveal CXCL12 as a Brown autocrine and paracrine chemokine
by: Marina Agueda-Oyarzabal, et al.
Published: (2025-03-01)